Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net revenues	$ 80	$ 57	$ 221	$ 217
Costs and operating expenses:
Cost of goods sold	189	106	555	347
Research and development	1,850	935	5,901	3,532
General and administrative	1,426	812	5,401	2,138
Total costs and operating expenses	3,465	1,853	11,857	6,017
Operating loss	(3,385)	(1,796)	(11,636)	(5,800)
Other income (expense):
Gain (loss) from changes in fair value of convertible notes payable (related party)	4,902	574	(13,332)	1,473
Other income (expense)	46	(117)	(59)	(119)
Total other income (expense), net	4,948	457	(13,391)	1,354
Net income (loss)	1,563	(1,339)	(25,027)	(4,446)
Net income (loss) attributable to common stockholders, basic	1,360	(1,339)	(25,027)	(4,446)
Net income (loss) attributable to common stockholders, diluted	$ 1,404	$ (1,339)	$ (25,027)	$ (4,446)
Net income (loss) per share attributable to common stockholders, basic (in Dollars per share)	$ 0.13	$ (0.13)	$ (2.46)	$ (0.44)
Net income (loss) per share attributable to common stockholders, diluted (in Dollars per share)	$ 0.13	$ (0.13)	$ (2.46)	$ (0.44)
Weighted-average common stock outstanding, basic (in Shares)	10,214,183	10,123,187	10,153,564	10,123,187
Weighted-average common stock outstanding, diluted (in Shares)	11,215,068	10,123,187	10,153,564	10,123,187
Other comprehensive loss:
Foreign currency translation adjustment	$ (1)	$ (3)	$ (1)	$ (3)
Other comprehensive loss	(1)	(3)	(1)	(3)
Comprehensive income (loss)	$ 1,562	$ (1,342)	$ (25,028)	$ (4,449)